Sign in

CIK 0001739104 · Large accelerated filer

Elanco Animal Health Inc

Sign in to watch
Ticker
ELAN
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
825497352
Phone
877-352-6261
Business address
450 ELANCO CIRCLE, INDIANAPOLIS, IN, 46221
  1. 8-K Event Executive or director change · Regulation FD disclosure
  2. 4 Open-market buy Director bought 20,000 shares at an average $10.55 ($211,000)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Director bought 25,000 shares at $10.90 ($272,558)
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 4 Grant or award SEE REMARKS acquired 22,105 shares (grant or award)
  9. 4 Grant or award SEE REMARKS acquired 64,103 shares (grant or award)
  10. 4 Grant or award SEE REMARKS acquired 50,575 shares (grant or award)
  11. 4 Grant or award SEE REMARKS acquired 30,947 shares (grant or award)
  12. 4 Grant or award PRESIDENT, CEO AND DIRECTOR acquired 265,252 shares (grant or award)
  13. 4 Grant or award SEE REMARKS acquired 28,736 shares (grant or award)
  14. 4 Grant or award GC AND CORP SEC acquired 30,947 shares (grant or award)
  15. 4 Grant or award SEE REMARKS acquired 44,209 shares (grant or award)
  16. 4 Grant or award CHIEF ACCOUNTING OFFICER acquired 12,158 shares (grant or award)
  17. 4 Grant or award SEE REMARKS acquired 22,105 shares (grant or award)
  18. 4 Grant or award EVP, MANUFACTURING AND QUALITY acquired 28,184 shares (grant or award)
  19. 4 Shares withheld for taxes SEE REMARKS gave up 18,196 shares (to pay taxes)
  20. 4 Shares withheld for taxes SEE REMARKS gave up 3,514 shares (to pay taxes)

Page 12 of 52 · 1,033 filings